HomePaxilNoven Pharmaceuticals Announces Issuance of New U.S. Patent, an Important
Posted in Paxil on 24th April 2014

Noven Pharmaceuticals Announces Issuance of New U.S. Patent, an Important
MIAMI and NEW YORK, March 25, 2014 /PRNewswire/ — Noven Pharmaceuticals, Inc. today announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 8,658,663, entitled "Method Of Treating Thermoregulatory Dysfunction With Paroxetine.
Read more on PR Newswire (press release)

Related Post for The Hat Trick Of Parkinson's, Homelessness and Depression

Study links use of antidepressants Paxil and Prozac with birth defects
Pharmacological treatment of acute and chronic panic disorder
If Alkermes Plc Recover From high profile failures?
Latest Paxil News
The Hat Trick Of Parkinson's, Homelessness and Depression